Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course
British Journal of Radiology · 01.11.2024 · 97 (1163) · 1740-1754
DOI: 10.1093/bjr/tqae180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Radiology, online erschienen am 05.09.2024. Verfasst von Sarah Poetter-Lang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090, Austria. Hauptthemen laut MEDLINE: Adenoma, Liver Cell, Liver Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hepatocellular adenomas (HCA) are acquired focal liver lesions, that occur mainly in young-to-middle-aged women who are on long-term estrogen-containing contraceptives or young men after prolonged use of anabolic steroids. Furthermore, distinct underlying diseases, such as obesity, metabolic dysfunction-associated steatotic liver disease, glycogen storage disease, etc. are considered risk factors. The 2017 Bordeaux classification, in particular Nault et al, divided HCAs into eight subtypes according to their pheno- and genotypic characteristics. This includes HCAs with hepatocyte-nuclear-factor (HNF1-alpha mutation), HCAs with β-catenin mutation, and HCAs without either of these genetic mutations, which are further subdivided into HCAs with and without inflammatory cells. HCAs should no longer be classified as purely benign without histologic workup since three of the eight subtypes are considered high-risk lesions, requiring adequate management: malignant transformation of the pure (ßex3-HCA) and mixed inflammatory/β-catenin exon 3 (ßex3-IHCA) adenomas, as well as potential bleeding of the sonic hedgehog HCA and pure (ßex7/8-HCA) and mixed inflammatory/β-catenin exon 7/8 (ßex7/8-IHCA). Elective surgery is recommended for any HCA in a male, or for any HCA exceeding 5 cm. Although MRI can classify up to 80% of adenomas, if findings are equivocal, biopsy remains the reference standard for adenoma subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090, Austria.
- Department of Radiology, University of Palermo, Palermo, 90133, Italy.
- Department of Pathology, Hôpital Beaujon-APHP Nord, Université Paris Cité, Clichy, 92110, Paris, France.
- Department of Radiology, Hôpital Beaujon-APHP Nord, Université Paris Cité, Clichy, 92110, Paris, France.
ORCID-Profile: Ahmed Ba-Ssalamah
Zitieren
APA
Poetter-Lang, S., Ba-Ssalamah, A., Bastati, N., Ba-Ssalamah, S. A., Hodge, J. C., Brancatelli, G., Paradis, V., & Vilgrain, V. (2024). Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. British Journal of Radiology, 97(1163), 1740-1754. https://doi.org/10.1093/bjr/tqae180
Vancouver
Poetter-Lang S, Ba-Ssalamah A, Bastati N, Ba-Ssalamah SA, Hodge JC, Brancatelli G, et al. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. British Journal of Radiology. 2024;97(1163):1740-1754. doi:10.1093/bjr/tqae180
BibTeX
@article{PoetterLang2024,
author = {Poetter-Lang, Sarah and Ba-Ssalamah, Ahmed and Bastati, Nina and Ba-Ssalamah, Sami A and Hodge, Jacqueline C and Brancatelli, Giuseppe and Paradis, Valérie and Vilgrain, Valérie},
title = {Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course},
journal = {British Journal of Radiology},
year = {2024},
volume = {97},
number = {1163},
pages = {1740--1754},
doi = {10.1093/bjr/tqae180}
}
EUVIMED